Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Talk:CD27

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia

Wiki Education Foundation-supported course assignment

[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 4 January 2021 and 15 March 2021. Further details are available on the course page. Student editor(s): Immcarle156.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 16:29, 16 January 2022 (UTC)Reply

What cell types is it found on

[edit]

? - Rod57 (talk) 12:08, 22 October 2015 (UTC)Reply

Edits in progress

[edit]

I will be adding new information to this page in the coming weeks. Below are the sources I will be using.

Buchan, S. L., Rogel, A., and Al-Shamkhani, A. (2018). The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood 131, 39-48. https://doi.org/10.1182/blood-2017-07-741025

Bullock, T. N. J. (2017). Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer. Curr. Opin. Immunol. 45, 82-88. https://doi.org/10.1016/j.coi.2017.02.001

Burugu, S., Dancsok, A. R., and Nielsen, T. O. (2018). Emerging targets in cancer immunotherapy. Semin. Cancer Biol. 52, 39-52. https://doi.org/10.1016/j.semcancer.2017.10.001

Sturgill, E. R. and Redmond, W. L. (2017). TNFR Agonists: A Review of Current Biologics Targeting OX40, 4-1BB, CD27, and GITR. AJHO 13, 4-15.

--Immcarle156 (talk) 17:04, 29 January 2021 (UTC)Reply